Latanoprost / Netarsudil Ophthalmic Dosage

Medically reviewed by Drugs.com. Last updated on Sep 18, 2024.

Usual Adult Dose for Intraocular Hypertension

Latanoprost 0.005%-netarsudil 0.02% ophthalmic solution: 1 drop into the affected eye(s) once a day in the evening

• Maximum dose: 1 drop/eye/day

Comment: Administration of other topical ophthalmic drugs to lower intraocular pressure (IOP) should be separated by at least 5 minutes.

Use: Reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension

Usual Adult Dose for Glaucoma (Open Angle)

Latanoprost 0.005%-netarsudil 0.02% ophthalmic solution: 1 drop into the affected eye(s) once a day in the evening

• Maximum dose: 1 drop/eye/day

Comment: Administration of other topical ophthalmic drugs to lower intraocular pressure (IOP) should be separated by at least 5 minutes.

Use: Reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

Missed doses:

• If a dose is missed, patients should continue with the next dose in the evening.
• The maximum daily dose is 1 drop in the affected eye per day.

Precautions

CONTRAINDICATIONS: None.

Safety and efficacy have not been established in pediatric patients.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

• During administration, patients should avoid touching tip of the single-use vial to the eye or any surface.
• Patients who require the use of other drugs to lower IOP should separate their administration by at least 5 minutes.

Storage requirements:

• The manufacturer product information should be consulted.

Patient advice:

• Patients should be instructed to avoid touching the vial tip to the eye or other surfaces.
• Patients who wear contact lenses should remove contact lenses before administration; the lenses may be reinserted at least 15 minutes after administration.
• Patients should be advised to speak to their healthcare provider if they become pregnant, intend to become pregnant, or are breastfeeding.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer